Editorial: Evidence-Based Anti-Inflammatory, Anti-Hypoperfusion and Anti-Anxiety/Insomnia Therapies Show Promises for TBI-Induced Post-Traumatic Symptoms and Cognitive Deficits: Advances in Diagnosis and Treatment of TBI-Induced Neurodegeneration and Cognitive Deficits.

Authors :: Xing G
Zhang Y
Zhang Y
Adamson MM
Furst AJ
Ashford JW
Source :: Frontiers in neurology [Front Neurol] 2021 Aug 11; Vol. 12, pp. 695629. Date of Electronic Publication: 2021 Aug 11 (Print Publication: 2021).
Publication Year :: 2021
Abstract: Competing Interests: GX was employed by company Lotus Biotech.com LLC. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Full Text Access

Tools